We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-3.47%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$119B
AUM Growth
-$5.47B
Cap. Flow
+$963M
Cap. Flow %
0.81%
Top 10 Hldgs %
23.93%
Holding
4,385
New
262
Increased
2,061
Reduced
1,644
Closed
273

Sector Composition

Rank Sector Weight
1 Technology 14.55%
2 Financials 8.81%
3 Healthcare 8.45%
4 Industrials 6.22%
5 Consumer Discretionary 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PATH icon
1451
UiPath
PATH
$8.64B
$5.45M ﹤0.01%
252,181
+34,597
+16% +$1.17M
AMWD
1452
DELISTED
American Woodmark
AMWD
$5.43M ﹤0.01%
110,978
+42,008
+61% +$2.42M
THRM icon
1453
Gentherm
THRM
$1.32B
$5.42M ﹤0.01%
74,200
+502
+0.7% +$41.8K
QAI icon
1454
NYLI Hedge Multi-Strategy Tracker ETF
QAI
$1.03B
$5.42M ﹤0.01%
175,670
+5,641
+3% +$175K
CDNA icon
1455
CareDx
CDNA
$2.45B
$5.42M ﹤0.01%
146,420
+9,067
+7% +$353K
URNM icon
1456
Sprott Uranium Miners ETF
URNM
$2B
$5.42M ﹤0.01%
130,214
+60,278
+86% +$2.22M
OUNZ icon
1457
VanEck Merk Gold Trust
OUNZ
$2.69B
$5.41M ﹤0.01%
287,450
+1,787
+0.6% +$32.6K
SDOG icon
1458
ALPS Sector Dividend Dogs ETF
SDOG
$1.45B
$5.4M ﹤0.01%
98,136
+8,994
+10% +$492K
ALNY icon
1459
Alnylam Pharmaceuticals
ALNY
$30.4B
$5.4M ﹤0.01%
33,060
-10,443
-24% -$1.59M
BCPC
1460
Balchem Corp
BCPC
$5.65B
$5.4M ﹤0.01%
39,489
+1,261
+3% +$181K
CHX
1461
DELISTED
ChampionX
CHX
$5.38M ﹤0.01%
219,968
-107,863
-33% -$2.5M
ITM icon
1462
VanEck Intermediate Muni ETF
ITM
$2.14B
$5.37M ﹤0.01%
113,553
-7,982
-7% -$393K
NORW icon
1463
Global X MSCI Norway ETF
NORW
$88.1M
$5.36M ﹤0.01%
167,842
+154,083
+1,120% +$4.71M
FERG icon
1464
Ferguson
FERG
$48B
$5.32M ﹤0.01%
39,694
-8,683
-18% -$1.34M
HSBC icon
1465
HSBC
HSBC
$358B
$5.32M ﹤0.01%
155,358
-1,032
-0.7% -$35.6K
VOOG icon
1466
Vanguard S&P 500 Growth ETF
VOOG
$27.4B
$5.32M ﹤0.01%
115,650
-3,120
-3% -$141K
LNT icon
1467
Alliant Energy
LNT
$18.2B
$5.31M ﹤0.01%
84,984
-5,532
-6% -$329K
SEM
1468
DELISTED
Select Medical
SEM
$5.3M ﹤0.01%
410,002
+98,884
+32% +$1.31M
CSL icon
1469
Carlisle Companies
CSL
$14.9B
$5.28M ﹤0.01%
21,472
+3,461
+19% +$811K
CHRW icon
1470
CALL
C.H. Robinson
CHRW
$17.5B
$5.28M ﹤0.01%
474,500
FYT icon
1471
First Trust Small Cap Value AlphaDEX Fund
FYT
$202M
$5.28M ﹤0.01%
103,295
+3,344
+3% +$173K
VVV icon
1472
Valvoline
VVV
$4.31B
$5.28M ﹤0.01%
167,173
-12,314
-7% -$402K
FYC icon
1473
First Trust Small Cap Growth AlphaDEX Fund
FYC
$1.41B
$5.27M ﹤0.01%
77,154
-58,542
-43% -$3.93M
SMDV icon
1474
ProShares Russell 2000 Dividend Growers ETF
SMDV
$708M
$5.25M ﹤0.01%
81,344
+4,152
+5% +$269K
ABM icon
1475
ABM Industries
ABM
$2.82B
$5.25M ﹤0.01%
114,110
+16,160
+16% +$703K

Similar funds

Raymond James & Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Raymond James & Associates held 4,385 positions worth $119B, down 4.4% from $124B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q1 2022 filing shows 262 new, 2,061 increased, 1,644 reduced and 273 closed positions. Its largest new stake was Shell: 688,334 shares worth $37.8M. The largest sale was iShares Ultra Short Duration Bond Active ETF, an estimated $172M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q1 2022 buy was Shell: 688,334 shares worth $37.8M.
  • Raymond James & Associates added most to Broadcom in Q1 2022, an estimated $236M increase.
  • Raymond James & Associates's biggest Q1 2022 reduction was iShares Ultra Short Duration Bond Active ETF, cutting an estimated $172M.
  • Raymond James & Associates fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $154M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $119B portfolio in Q1 2022.
  • Raymond James & Associates opened 262 new positions and closed 273 in Q1 2022.
  • Raymond James & Associates's portfolio value fell 4.4% quarter-over-quarter to $119B.

Based on Raymond James & Associates's 13F filing for Q1 2022, filed 11 May 2022.